According to standard clinical guidance and Omzo's own eligibility framing, licensed clinicians evaluating GLP-1 candidacy typically consider factors like body mass index, medical history, existing conditions (particularly thyroid disease, pancreatitis, or other contraindications for GLP-1 medications), current medications, and personal health goals
doi:10.1007/s10815-021-02247-5
Through NovoCare self-pay, Wegovy is listed at $199 per month for the first two qualifying fills, then $349 per month for standard doses under current manufacturer terms verify NovoCare before comparing
Im very excited about it, because I think now we have a chance to really understand this down to the cellular level, says Trapp
Generic liraglutide (Nevolat) is typically cheaper, costing between 70 and 160 per month from UK online pharmacies